chondrogenic differentiation medium diff (ATCC)
Structured Review
Chondrogenic Differentiation Medium Diff, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chondrocyte+differentiation+tool/Chondrocyte+Differentiation+Tool/pm39128191-78-47-54
Average 92 stars, based on 6 article reviews
Images
Related Articles
Differentiation Assay:Article Title: Suppression of microRNA-205-5p in human mesenchymal stem cells improves their therapeutic potential in treating diabetic foot disease Article Snippet: .. Chondrogenetic differentiation assay of MSCs was performed using Article Title: Immortalized Human Bone Marrow Derived Stromal Cells in Treatment of Transient Cerebral Ischemia in Rats Article Snippet: Cerebral ischemic stroke may cause a number of adverse neurological complications or behavioral disorders.. Moreover, cerebral ischemic stroke is a prevalent disease with limited treatment strategies and may increase chances of developing neurodegenerative diseases, e.g., Alzheimer’s disease, in the future.. Therefore, alternative strategies are highly needed for improving the therapy for ischemic stroke. Flow Cytometry:Article Title: IL-8 Enhances Therapeutic Effects of BMSCs on Bone Regeneration via CXCR2-Mediated PI3k/Akt Signaling Pathway. Article Snippet: .. The phenotype of mBMSCs were evaluated by flow cytometry analysis of the surface markers Sca-1, CD90, CD105, CD34, CD45 and HLA-DR, and inducible differentiation of mBMSCs into osteocytes, adipocytes and chondrocytes with Osteocyte Differentiation Tool (American Type Culture Collection (ATCC), Rockville, MD, USA; Catalog number: PCS-500-052), Adipocyte Differentiation Toolkit (ATCC; Catalog number: PCS-500-050) and |

